EMPLOYEES 17 Organization of work The proportion of women within the management committee was As at December 31, 2017, out of 34 employees, 8 were senior 44% in 2017, 6 pts increase compared to 2016. managers (“cadre dirigeant”), 25 were managers (“cadre”) and one GenSight Biologics does not employ any disabled persons, and was a non-manager (“non-cadre”). Managers and non-managers does not pay an annual financial contribution to the Agefiph, worked 37 hours weekly and were compensated by 12 days of the French public agency that promotes integration into the additional holiday (“Réduction du Temps de Travail”). workplace of disabled people, because in 2017, GenSight As at December 31, 2017, 88% of employees were full-time and Biologics is exempt. 12% were part-time. 97% of employees GenSight Biologics are based in France and The table below presents the absenteeism rate for the years 2016 3% in United States. The Company complies with all applicable and 2017: regulations. Furthermore, France has ratified the eight fundamental 2016 2017 conventions of the ILO. The ILO has qualified as “fundamental Absenteeism rate 1.75% 1.56% agreements” the conventions concerning the following principles and fundamental labor rights: freedom to unionize and effective Corporate dialogue recognition of the right of collective bargaining, elimination of Given the size of the Company and the number of employees, forced or compulsory work, effective abolition of child labor corporate dialogue is a natural component of the working and elimination of discrimination in the area of employment and environment at GenSight Biologics. Personnel representatives profession. elections took place on April 3, 2015. The Company acknowledged GenSight Biologics shares these principles, which are implemented the absence of a candidate. in the Company’s social relations, its policy regarding recruitment and equality of opportunity. Health & Safety In compliance with regulations, GenSight Biologics has carried out in its “Document Unique d’Entreprise” a risk analysis of its activities 17.3 and proposed an action plan to mitigate these risks. SHAREHOLDINGS AND SHARE WARRANTS OR No accident at work nor any work-related disease was declared SHARE WARRANTS FOR FOUNDERS HELD BY in 2017. MEMBERS OF THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT GenSight Biologics considers that it does not expose its employees See Section 15, “Compensation and Benefits” of this Registration to any specific risk. Document. Training The Company aims to provide its employees with training 17.4 opportunities, to develop general skil ls (management and EMPLOYEE SHAREHOLDING PLAN AND LONG- languages, etc.) as well as technical skills specific to each position.TERM INCENTIVE PLANS 2016 2017 See Section 15, “Compensation and Benefits” of this Registration Number of training hours taken 27 262 (1) Document. (1) Including 188 hours of language learning in 2017. Diversity 17.5 GenSight Biologics gives special attention to the diversity of its PROFIT-SHARING AGREEMENTS AND INCENTIVE teams. The distribution by sex, as presented in the table below, is a SCHEMES meaningful measure of this commitment: None. 2016 2017 Percentage of female employees 56% 59% GENSIGHT BIOLOGICS – 2017 Registration Document– 173